Samsung Biologics is committed to sustainable operations and has published its 2025 ESG Report outlining ESG initiatives, strategies, and plans for 2024–2025. The company received the Terra Carta Seal and has established net-zero targets by 2050. Samsung Biologics is recognized among top sustainable companies in the Dow Jones Sustainability World Index for embedding sustainable business practices across operations, particularly through robust environmental efforts. The company is paving the way for a more sustainable biopharmaceutical industry by embedding sustainability across the value chain.
About Samsung Biologics
- Status
- Unverified
- Website
- Visit Website
Samsung Biologics Sustainability Actions
Samsung Biologics Sustainability Commitments
2050
Net-Zero Emissions Target
Samsung Biologics aims to achieve net-zero greenhouse gas emissions in its operations by 2050.
2025
100% Renewable Energy
Samsung Biologics is moving towards 100% renewable energy use in its operations.
